The dynamics of the Friedreich's ataxia market are anticipated to change as companies across the globe are thoroughly working toward the deve ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

The market for Ataxia-Telangiectasia is wide open, and Quince’s treatment eDSP builds on teachings of a previous trial. In case of success, I believe the platform potential of the AIDE ...

I am pleased to confirm the first UK approval for the treatment of Friedreich’s ataxia, omaveloxolone. “We’re assured that the appropriate regulatory standards of safety, quality ...

An Edmond family is on a mission to find a cure. For a decade, Michael Gehr has been battling Friedreich's ataxia, a rare ...

The Spinocerebellar Ataxia pipeline is advancing fast as troriluzole nears FDA nod and rivals race with gene and stem cell therapies to seize market edge. Disease modification in spinocerebellar ...

Dr. Pampinella had spent a great deal of money in trying to perfect an apparatus for the cure of locomotor ataxia, and it is believed that financial embarrassment caused him to end his life.

to its investigational anti-sense Oligonucleotide therapeutic for the treatment of Spinocerebellar Ataxia (SCA), including Spinocerebellar Ataxia Type 3 (SCA3), a progressive and currently ...

There are several current treatment options for Friedreich's ataxia, or FA as I'll call it for the rest of this time. The most important is what we had before the approval of any drugs.

In the case of locomotor ataxia it was found that pain produced in the early stages of the disease could be stopped and prevented. In advanced cases, while no cure could be effected, a return of ...